High-dose mitoxantrone-vinblastine-cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study.
about
Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen.Metabolism and transport of oxazaphosphorines and the clinical implications.A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation.
P2860
High-dose mitoxantrone-vinblastine-cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
High-dose mitoxantrone-vinblas ...... prospective multicentre study.
@en
High-dose mitoxantrone-vinblas ...... prospective multicentre study.
@nl
type
label
High-dose mitoxantrone-vinblas ...... prospective multicentre study.
@en
High-dose mitoxantrone-vinblas ...... prospective multicentre study.
@nl
prefLabel
High-dose mitoxantrone-vinblas ...... prospective multicentre study.
@en
High-dose mitoxantrone-vinblas ...... prospective multicentre study.
@nl
P2093
P2860
P356
P1433
P1476
High-dose mitoxantrone-vinblas ...... prospective multicentre study
@en
P2093
A H G Paterson
D A Stewart
J D Ruether
P Craighead
P2860
P304
P356
10.1093/ANNONC/MDI268
P577
2005-06-09T00:00:00Z